arrow
Y

Yunqi Zhao

Southeast University
H指数:14
被引数:563
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer cell-selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy
2026-09-010
OAAI
NF-κB-driven immune checkpoint knockdown and cytokine expression in cancer cells for tumor immunotherapy

NF-κB驱动的免疫检查点敲低和细胞因子表达在癌细胞中对肿瘤免疫治疗的应用

2026-08-240
OAAI
Tumor Assembloids as Three-Dimensional Platforms for Modeling Drug Delivery Barriers: Construction Strategies; Applications; and Translational Challenges

肿瘤组装体作为药物递送屏障建模的三维平台:构建策略、应用及转化挑战

2026-07-140
OAAI
Harnessing Organoid Platforms for Nanoparticle Drug Development

利用类器官平台进行纳米颗粒药物开发

2025-07-180
OA
Metabolomics-based discrimination of geographical variability in quality and antioxidant activity of golden mushroom (Floccularia luteovirens) from the Qinghai-Tibet Plateau

基于代谢组学的青藏高原金色蘑菇(Floccularia luteovirens)地理变异性在品质和抗氧化活性方面的区分

2025-06-011
PRE
Smart Polymeric Nanoparticles in Cancer Immunotherapy
2023-02-2626
OAAI
The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium-Resveratrol Conjugate on Breast Cancer Cells
2022-10-157
OAAI
Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
2022-04-2016
OAAI
Sequential Drug Delivery in Targeted Cancer Therapy

肿瘤靶向治疗中的序贯给药

2022-03-0520
OAAI
Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative (vol 7, pg 582, 2017)
2018-08-020
OAAI
Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative
2017-05-0112
OAAI
PROSTATE CANCER-TARGETED DELIVERY OF NANOMICELLE-LOADED WITH P110BETA-SPECIFIC INHIBITOR TGX221 PRO-DRUGS SUPPRESSES XENOGRAFT TUMOR GROWTH
2013-04-010
PREAI
Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(dl-lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
2012-10-0149
OAAI